CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$45.15 -4.89 (-9.77%)
At close: Nov 10, 2026 · 4:00 PM EST

CRISPR Therapeutics AG (CRSP) Net Long-Term Debt Issued (Repaid) (2016 - 2026)

Updated

CRISPR Therapeutics AG (CRSP) posted Net Long-Term Debt Issued (Repaid) of $600 million for Q1 2026.

Analysis

CRISPR Therapeutics AG (CRSP) Net Long-Term Debt Issued (Repaid) (2016 - 2026) Analysis & Trends

For FY2016, CRISPR Therapeutics AG's Net Long-Term Debt Issued (Repaid) came in at $35.01 million, down 8.4% from FY2015.

  • In prior years, CRISPR Therapeutics AG's Net Long-Term Debt Issued (Repaid) was $38.24 million in FY2015.
  • The Q1 2026 figure stands as the lowest quarterly Net Long-Term Debt Issued (Repaid) since Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -1.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 9.98 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 CRISPR Therapeutics AG 4.65 Bn -4.41 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 600.00 Mn
Dec 31, 2016 10,000.00
Mar 31, 2016 35.00 Mn
API Access

CRISPR Therapeutics AG Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=CRSP&period=max&api_key=YOUR_API_KEY